To include your compound in the COVID-19 Resource Center, submit it here.

Ultragenyx, Dimension make deal official

On Oct. 3, rare disease company Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) said it will acquire gene therapy play Dimension Therapeutics

Read the full 199 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE